This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignee: Incyte Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Shicheng Shi: Innovator in Tetracyclic Compounds
Introduction
Shicheng Shi is a prominent inventor based in Princeton, NJ (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of tetracyclic compounds. With a total of 2 patents, his work focuses on innovative solutions for treating various diseases, including cancer.
Latest Patents
Shicheng Shi's latest patents include groundbreaking research on tetracyclic compounds as diacylglycerol kinase (DGK) inhibitors. These compounds are designed to modulate the activity of DGK, which plays a crucial role in cellular signaling pathways. The applications of these compounds are particularly promising in the treatment of cancer and other related diseases.
Career Highlights
Shicheng Shi is currently associated with Incyte Corporation, where he continues to advance his research in pharmacology and medicinal chemistry. His work has garnered attention for its potential impact on therapeutic strategies in oncology.
Collaborations
Some of his notable coworkers include Xiaozhao Wang and Joshua Hummel, who collaborate with him on various research projects aimed at enhancing the efficacy of cancer treatments.
Conclusion
Shicheng Shi's innovative work in the field of tetracyclic compounds positions him as a key figure in the ongoing fight against cancer. His contributions are paving the way for new therapeutic options that could significantly improve patient outcomes.